Methotrexate revisited: considerations for subcutaneous administration in RA
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methotrexate revisited: considerations for subcutaneous administration in RA
Authors
Keywords
Methotrexate, Polyglutamates, Rheumatoid arthritis, Subcutaneous
Journal
CLINICAL RHEUMATOLOGY
Volume 34, Issue 2, Pages 201-205
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1007/s10067-014-2830-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
- (2014) Michael H Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis
- (2014) Ediz Dalkilic et al. Modern Rheumatology
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate
- (2013) Ray Fitzpatrick et al. CLINICAL RHEUMATOLOGY
- Rheumatoid arthritis and risk of acute myocardial infarction—A nationwide retrospective cohort study
- (2013) Wei-Sheng Chung et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Subcutaneous Methotrexate to Cut Costs?: Table 1.
- (2012) ROYA HASSANZADEH et al. JOURNAL OF RHEUMATOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
- (2011) LISA K. STAMP et al. JOURNAL OF RHEUMATOLOGY
- Methotrexate: Optimizing the Efficacy in Rheumatoid Arthritis
- (2011) Jürgen Braun Therapeutic Advances in Musculoskeletal Disease
- Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke
- (2010) H. Kallberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study
- (2010) M. F. Bakker et al. ANNALS OF THE RHEUMATIC DISEASES
- An update on methotrexate
- (2010) Juergen Braun et al. CURRENT OPINION IN RHEUMATOLOGY
- What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases
- (2009) Jacqueline E Oliver et al. ARTHRITIS RESEARCH & THERAPY
- Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
- (2008) Sherine E. Gabriel AMERICAN JOURNAL OF MEDICINE
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
- (2008) K Visser et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now